drugset / Trial / NCT03960008
Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
Phase 3
Terminated
9 enrolled
Lahey Clinic
Merit Medical Systems, Inc. · collabVarian Medical Systems · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing liver transplantation. We propose that SBRT will be associated with longer time intervals between initial treatment and the need for retreatment, compared to TACE, as a "bridge" to liver transplantation in subjects with HCC.
Timeline
- Start
- 2020-03-01
- Primary completion
- 2024-02-28
- Completion
- 2024-02-28
Outcome
Outcome not reported
Stopped (Enrollment): “This study was closed early due to lack of enrollments and insufficient funding.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubin | Unknown | 50 mg | — |